Edition:
United Kingdom

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.55USD
21 Sep 2018
Change (% chg)

$-0.10 (-0.73%)
Prev Close
$13.65
Open
$13.60
Day's High
$13.90
Day's Low
$13.35
Volume
597,445
Avg. Vol
263,888
52-wk High
$19.80
52-wk Low
$6.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.340
Mar '18 0.00 -0.314
FY 2017 Dec '17 0.00 -0.355
Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 7 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 0.00 0.00 0.00 16.67
Earnings (per share)
Quarter Ending Sep-18 7 -0.33 -0.30 -0.36 -0.34
Quarter Ending Dec-18 7 -0.34 -0.30 -0.37 -0.31
Year Ending Dec-18 7 -1.32 -1.24 -1.39 -1.47
Year Ending Dec-19 7 -1.43 -1.24 -1.62 -1.45
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 4.58 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 3.81 15.51 5.00
Price to Tangible Book (MRQ) 4.28 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 74.69 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -65.35 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -199.13 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 117.78 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 15.29 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,229,030 860,305,024
Net Income/Employee (TTM) -1,539,353 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.36 -0.15 11.13
Return on Assets - 5 Yr. Avg. -46.95 3.51 12.40
Return on Investment (TTM) -49.36 1.79 14.61
Return on Investment - 5 Yr. Avg. -52.23 2.56 16.13
Return on Equity (TTM) -80.46 3.28 16.33
Return on Equity - 5 Yr. Avg. -77.17 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -197.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.53 3.83 99 52
13 Week 15.44 9.82 99 66
26 Week 19.85 10.74 99 80
52 Week 1.29 -14.15 99 50
YTD 12.95 -0.81 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.45%
# of Holders: 186
Total Shares Held: 89,331,523
3 Mo. Net Change: 6,850,170
# New Positions: 32
# Closed Positions: 25
# Increased Positions: 106
# Reduced Positions: 66
# Net Buyers: 40
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.